BLRX
BioLineRX LtdRecent alerts on BLRX
All signals →
News
BioLineRx (BLRX) Q1 2026 Earnings Transcript
3d ago
News
BioLineRx GAAP EPS of $0.00 beats by $1.04, revenue of $0.48M beats by $0.14M
6d ago
SEC filing
BLRX Doses 1st Patient in GLIX1 GBM Trial, $0.5M Royalties, $17.4M Cash
6d ago
SEC filing
BLRX and Hemispherian Report GLIX1 Preclinical Data Showing Potent Anti-Tumor Effect in Glioblastoma Models
14d ago
SEC filing
BLRX Initiates Phase 1/2a GLIX1 Study for GBM, Oral TET2 Activator, 30-Patient MTD Trial, NYU Langone Leads, Data H1 2027
68d ago
SEC filing
BLRX Reports $20.9M Cash, $0.00 EPS, Announces Phase 1/2a GLIX1 GBM Trial Start, Patent Allowed Until 2040, Motixafortide Pancreatic Trial Accelerated
71d ago
Scanner
Unusual volume (10.7x average)
125d ago
News
Evocative Raises Financing to Fuel Continued Growth
168d ago
News
Medical Supplier Medline Guides IPO to Upper Half of Price Range
168d ago
News
Kenya Awards AfDB and Power Grid India $311 Million Deal for Lines
169d ago
News
Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
169d ago
Get push alerts for BLRX
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS